Literature DB >> 16813897

Renal function in patients with nephrolithiasis.

Elaine M Worcester1, Joan H Parks, Andrew P Evan, Fredric L Coe.   

Abstract

PURPOSE: We describe kidney function, as measured by creatinine clearance in stone formers, and classified by type of stone formed and systemic etiologies of stone formation.
MATERIALS AND METHODS: The mean of 3 pretreatment 24-hour creatinine clearance measurements in each of 1,856 stone formers and creatinine clearance in 153 normal individuals were used. Clearance was adjusted for patient sex, age and body weight using general linear modeling.
RESULTS: As a group, all stone formers had decreased clearance adjusted for age, sex and body weight compared to that in normal individuals. Although clearance was particularly low in cystine and struvite stone formers, they were below normal in even common CaOx stone formers.
CONCLUSIONS: As a rule, patients with kidney stones do not have normal kidney function. In clinical management all efforts must be made to minimize renal injury, balancing the risks of obstruction from stones against those of urological procedures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813897     DOI: 10.1016/j.juro.2006.03.095

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  33 in total

1.  Clinical characteristics of potential kidney donors with asymptomatic kidney stones.

Authors:  Elizabeth C Lorenz; John C Lieske; Terri J Vrtiska; Amy E Krambeck; Xujian Li; Eric J Bergstralh; L Joseph Melton; Andrew D Rule
Journal:  Nephrol Dial Transplant       Date:  2011-02-01       Impact factor: 5.992

Review 2.  Nephrolithiasis.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

3.  Lime powder treatment reduces urinary excretion of total protein and transferrin but increases uromodulin excretion in patients with urolithiasis.

Authors:  Piyaratana Tosukhowong; Pimsuda Kulpradit; Sakdithep Chaiyarit; Wattanachai Ungjareonwattana; Nuttiya Kalpongnukul; Supoj Ratchanon; Visith Thongboonkerd
Journal:  Urolithiasis       Date:  2017-06-05       Impact factor: 3.436

4.  Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein.

Authors:  Yan Liu; Lan Mo; David S Goldfarb; Andrew P Evan; Fengxia Liang; Saeed R Khan; John C Lieske; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-30

5.  Clinical, demographic, and laboratory characteristics of children with nephrolithiasis.

Authors:  David J Sas; Lauren J Becton; Jeffrey Tutman; Laura A Lindsay; Amy H Wahlquist
Journal:  Urolithiasis       Date:  2015-10-14       Impact factor: 3.436

Review 6.  Genetic determinants of urolithiasis.

Authors:  Carla G Monico; Dawn S Milliner
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

7.  Uric acid stones increase the risk of chronic kidney disease.

Authors:  Ching-Chia Li; Tsu-Ming Chien; Wen-Jeng Wu; Chun-Nung Huang; Yii-Her Chou
Journal:  Urolithiasis       Date:  2018-02-28       Impact factor: 3.436

8.  Stone composition and vascular calcifications in patients with nephrolithiasis.

Authors:  Pietro Manuel Ferraro; Riccardo Marano; Aniello Primiano; Jacopo Gervasoni; Matteo Bargagli; Giuseppe Rovere; Pier Francesco Bassi; Giovanni Gambaro
Journal:  J Nephrol       Date:  2019-06-04       Impact factor: 3.902

9.  Kidney Function After the First Kidney Stone Event.

Authors:  William E Haley; Felicity T Enders; Lisa E Vaughan; Ramila A Mehta; Maxton E Thoman; Terri J Vrtiska; Amy E Krambeck; John C Lieske; Andrew D Rule
Journal:  Mayo Clin Proc       Date:  2016-10-21       Impact factor: 7.616

Review 10.  Idiopathic hypercalciuria and formation of calcium renal stones.

Authors:  Fredric L Coe; Elaine M Worcester; Andrew P Evan
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.